Regeneron Acquires 23andMe for $256M Amid Bankruptcy and Data Privacy Concerns
May 18, 2025 – BlogHear.com DNA testing pioneer 23andMe has officially announced its acquisition by Regeneron Pharmaceuticals for $256 million, just two months after filing for bankruptcy protection in the United States. The agreement, which was finalized through an auction as part of the bankruptcy proceedings, allows Regeneron to absorb nearly all of 23andMe’s assets….